» Articles » PMID: 30855982

Neuroimaging Reward, Craving, Learning, and Cognitive Control in Substance Use Disorders: Review and Implications for Treatment

Overview
Journal Br J Radiol
Specialty Radiology
Date 2019 Mar 12
PMID 30855982
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Substance use disorder is a leading causes of preventable disease and mortality. Drugs of abuse cause molecular and cellular changes in specific brain regions and these neuroplastic changes are thought to play a role in the transition to uncontrolled drug use. Neuroimaging has identified neural substrates associated with problematic substance use and may offer clues to reduce its burden on the patient and society. Here, we provide a narrative review of neuroimaging studies that have examined the structures and circuits associated with reward, cues and craving, learning, and cognitive control in substance use disorders. Most studies use advanced MRI or positron emission tomography (PET). Many studies have focused on the dopamine neurons of the ventral tegmental area, and the regions where these neurons terminate, such as the striatum and prefrontal cortex. Decreases in dopamine receptors and transmission have been found in chronic users of drugs, alcohol, and nicotine. Recent studies also show evidence of differences in structure and function in substance users relative to controls in brain regions involved in salience evaluation, such as the insula and anterior cingulate cortex. Balancing between reward-related bottom-up and cognitive-control-related top-down processes is discussed in the context of neuromodulation as a potential treatment. Finally, some of the challenges for understanding substance use disorder using neuroimaging methods are discussed.

Citing Articles

Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.

Nikolova Y, Ruocco A, Felsky D, Lange S, Prevot T, Vieira E medRxiv. 2024; .

PMID: 39252904 PMC: 11383479. DOI: 10.1101/2024.08.30.24312806.


Neuroimaging of the effects of drug exposure or self-administration in rodents: A systematic review.

Drossel G, Heilbronner S, Zimmermann J, Zilverstand A Neurosci Biobehav Rev. 2024; 164:105823.

PMID: 39094280 PMC: 11374361. DOI: 10.1016/j.neubiorev.2024.105823.


Unveiling the link between chronic pain and misuse of opioids and cannabis.

Dagher M, Alayoubi M, Sigal G, Cahill C J Neural Transm (Vienna). 2024; 131(5):563-580.

PMID: 38570361 DOI: 10.1007/s00702-024-02765-3.


Distinct neurochemical influences on fMRI response polarity in the striatum.

Cerri D, Albaugh D, Walton L, Katz B, Wang T, Chao T Nat Commun. 2024; 15(1):1916.

PMID: 38429266 PMC: 10907631. DOI: 10.1038/s41467-024-46088-z.


An electroencephalographic signature predicts craving for methamphetamine.

Tian W, Zhao D, Ding J, Zhan S, Zhang Y, Etkin A Cell Rep Med. 2023; 5(1):101347.

PMID: 38151021 PMC: 10829728. DOI: 10.1016/j.xcrm.2023.101347.


References
1.
Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A . Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009; 104(4):653-60. DOI: 10.1111/j.1360-0443.2008.02448.x. View

2.
Everitt B, Robbins T . Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On. Annu Rev Psychol. 2015; 67:23-50. DOI: 10.1146/annurev-psych-122414-033457. View

3.
Koob G, Volkow N . Neurocircuitry of addiction. Neuropsychopharmacology. 2009; 35(1):217-38. PMC: 2805560. DOI: 10.1038/npp.2009.110. View

4.
Scaramella L, KEYES A . The social contextual approach and rural adolescent substance use: implications for prevention in rural settings. Clin Child Fam Psychol Rev. 2002; 4(3):231-51. DOI: 10.1023/a:1017599031343. View

5.
Martinez D, Carpenter K, Liu F, Slifstein M, Broft A, Friedman A . Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry. 2011; 168(6):634-41. PMC: 3235735. DOI: 10.1176/appi.ajp.2010.10050748. View